Journal
JOURNAL OF ORTHOPAEDIC RESEARCH
Volume 32, Issue 1, Pages 116-122Publisher
WILEY-BLACKWELL
DOI: 10.1002/jor.22485
Keywords
carpal tunnel syndrome; subsynovial connective tissue; TGF-beta; CTGF
Categories
Funding
- NIAMS NIH HHS [F32 AR063596, T32 AR056950, R01 AR049823] Funding Source: Medline
Ask authors/readers for more resources
Non-inflammatory fibrosis of the subsynovial connective tissue (SSCT) is a hallmark of carpal tunnel syndrome (CTS). The etiology of this finding and its relationship to the development of CTS remain poorly understood. Recent studies have found that transforming growth factor-beta (TGF-beta) plays a central role in fibrosis. The purpose of this study was to investigate the expression of TGF-beta and connective tissue growth factor (CTGF), a downstream mediator of TGF-beta, in the pathogenesis of CTS. We compared SSCT specimens from 26 idiopathic CTS patients with specimens from 10 human cadaver controls with no previous diagnosis of CTS. Immunohistochemistry was performed to determine levels TGF-beta 1, CTGF, collagen 1(Col1) and collagen 3 (Col3) expression. TGF-beta 1 (p<0.01), CTGF (p<0.01), and Col3 (p<0.01) were increased in SSCT of CTS patients compared with control tissue. In addition, a strong positive correlation was found between TGF-beta 1 and CTGF, (R-2 - 0.80, p<0.01) and a moderate positive correlation between Col3 and TGF-beta 1 (R-2 = 0.49, p<0.01). These finding suggest that there is an increased expression of TGF-beta and CTGF, a TGF-beta regulated protein, and that this TGF-beta activation may be responsible for SSCT fibrosis in CTS patients. (C) 2013 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available